Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients

Athanasos, 2006, Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations, Pain, 120, 267, 10.1016/j.pain.2005.11.005 Barrett, 2005, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, 21, 263, 10.1093/bioinformatics/bth457 Bart, 2005, Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden, Neuropsychopharmacology, 30, 417, 10.1038/sj.npp.1300598 Bond, 1998, Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction, Proc. Natl. Acad. Sci. U. S. A., 95, 9608, 10.1073/pnas.95.16.9608 Bunten, 2010, OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths, Clin. Pharmacol. Ther., 88, 383, 10.1038/clpt.2010.127 Bunten, 2011, CYP2B6 and OPRM1 gene variations predict methadone-related deaths, Addict. Biol., 16, 142, 10.1111/j.1369-1600.2010.00274.x Compton, 2003, Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction, Am. J. Med. Genet. B., 121B, 76, 10.1002/ajmg.b.20057 Crettol, 2008, Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1722, 10.1016/j.pnpbp.2008.07.009 Crystal, 2012, A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women, Addict. Biol., 17, 181, 10.1111/j.1369-1600.2010.00265.x Deb, 2010, Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction, J. Neurochem., 112, 486, 10.1111/j.1471-4159.2009.06472.x Donny, 2005, Methadone doses of 100mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers, Addiction, 100, 1496, 10.1111/j.1360-0443.2005.01232.x Fillingim, 2005, The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans, J. Pain, 6, 159, 10.1016/j.jpain.2004.11.008 Fonseca, 2010, Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes, Mol. Diagn. Ther., 14, 171, 10.1007/BF03256370 Franke, 2001, Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence, Am. J. Med. Genet., 105, 114, 10.1002/1096-8628(20010108)105:1<114::AID-AJMG1074>3.0.CO;2-L Hanbury, 1977, Adequacy of sexual performance in men maintained on methadone, Am. J. Drug Alcohol Abuse, 4, 13, 10.3109/00952997709002743 Hartel, 1995, Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use, Am. J. Public Health, 85, 83, 10.2105/AJPH.85.1.83 Hayashida, 2008, Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype, Pharmacogenomics, 9, 1605, 10.2217/14622416.9.11.1605 Johnson, 2008, Inhibitory and excitatory effects of micro-, delta-, and kappa-opioid receptor activation on breathing in awake turtles, Trachemys scripta, Am. J. Physiol. Regul. Integr. Comp. Physiol., 295, R1599, 10.1152/ajpregu.00020.2008 Klepstad, 2004, The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease, Acta Anaesthesiol. Scand., 48, 1232, 10.1111/j.1399-6576.2004.00517.x Kreek, 1996, Opiates, opioids and addiction, Mol. Psychiatry, 1, 232 Kurth, 2009, Insomnia among methadone-maintained individuals: the feasibility of collecting home polysomnographic recordings, J. Addict. Dis., 28, 219, 10.1080/10550880903014155 Lotsch, 2005, Are mu-opioid receptor polymorphisms important for clinical opioid therapy?, Trends Mol. Med., 11, 82, 10.1016/j.molmed.2004.12.006 Lotsch, 2006, Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers, Pharmacogenomics J., 6, 200, 10.1038/sj.tpj.6500362 Marsden, 2008, Development of the treatment outcomes profile, Addiction, 103, 1450, 10.1111/j.1360-0443.2008.02284.x Martin, 2007, Differential regional effects of methadone maintenance compared to heroin dependence on £g-opioid receptor desensitization in rat brain, Synapse, 61, 176, 10.1002/syn.20355 Mattick, 2009, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst. Rev., 3, 1 Narita, 2001, Regulations of opioid dependence by opioid receptor types, Pharmacol. Ther., 89, 1, 10.1016/S0163-7258(00)00099-1 Nishizawa, 2006, Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population, Neuropsychobiology, 53, 137, 10.1159/000093099 Oertel, 2009, A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain, J. Biol. Chem., 284, 6530, 10.1074/jbc.M807030200 Oroszi, 2009, OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach, Alcoholism (NY), 33, 383, 10.1111/j.1530-0277.2008.00846.x Pan, 2009, Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions, Proc. Natl. Acad. Sci. U. S. A., 106, 4917, 10.1073/pnas.0811586106 Ray, 2006, Association of OPRM1 A118G variant with the relative reinforcing value of nicotine, Psychopharmacology, 188, 355, 10.1007/s00213-006-0504-2 Rodi, 2002, A strategy for the rapid discovery of disease markers using the MassARRAY system, Biotechniques, 32, S62, 10.2144/jun0204 Roy, 1998, mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit, Mol. Brain Res., 56, 281, 10.1016/S0169-328X(98)00051-5 Shabalina, 2009, Expansion of the human mu-opioid receptor gene architecture: novel functional variants, Hum. Mol. Genet., 18, 1037, 10.1093/hmg/ddn439 Sharkey, 2011, Assessing sleep in opioid dependence: a comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patients, Drug Alcohol Depend., 113, 245, 10.1016/j.drugalcdep.2010.08.007 Shi, 2002, Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin, Hum. Mutat., 19, 459, 10.1002/humu.9026 Storey, 2003, The positive false discovery rate: a Bayesian interpretation and the q-value, Ann. Stat., 31, 2013, 10.1214/aos/1074290335 Tost, 2005, Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications, Clin. Biochem., 38, 335, 10.1016/j.clinbiochem.2004.12.005 Trksak, 2010, Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging study, Drug Alcohol Depend., 106, 79, 10.1016/j.drugalcdep.2009.07.022 Walter, 2009, Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment, Pain, 146, 270, 10.1016/j.pain.2009.07.013 Wang, 2010, Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients, Biomed. Chromatogr., 24, 782, 10.1002/bmc.1363 Way, 2009, Variation in the mu-opioidreceptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection, Proc. Natl. Acad. Sci. U. S. A., 106, 15079, 10.1073/pnas.0812612106 Wesson, 2003, The Clinical Opiate Withdrawal Scale (COWS), J. Psychoactive Drugs, 35, 253, 10.1080/02791072.2003.10400007 Wolff, 1991, Methadone concentrations in plasma and their relationship to drug dosage, Clin. Chem., 37, 205, 10.1093/clinchem/37.2.205 Xin, 2002, Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants, AAPS PharmSci, 4, E23, 10.1208/ps040423 Yuan, 2006, FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization, Nucleic Acids Res., 34, W635, 10.1093/nar/gkl236